Nature Medicine reports on the development of a new oral GLP-1 drug designed to treat obesity. Unlike current peptide-based treatments that require subcutaneous injection, this non-peptide version is administered as a pill, offering easier storage and usage. The advancement aims to improve accessibility and adherence for patients requiring weight management therapies.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.